Dec 21, 2020 · 58m · capital-allocators
André Perold – Pockets of Inefficiency at HighVista Strategies (Capital Allocators, EP.169)
0:00 / 0:00
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this episode of Capital Allocators, host Ted Seides interviews André Perold, CIO of HighVista Strategies, exploring how the firm transitioned from traditional endowment asset buckets to an unconstrained, bottom-up model capturing idiosyncratic alpha across niche markets like biotechnology, private credit, and litigation finance.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Ted holds 20.9% of the talking time here. How this is scored →
Ted as informed peer 3.3 Guest teaching 2.7 Guest disagreement 0.3 Ted pushing back 0.6
speaking balance: gold is Ted, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 51:10 Calling Out Industry Conformity and Fake Originality
Andre criticizes investment industry peers for herd mentality, pointing out that almost everyone pretends to do original work while simply copying each other.
Hardest push from Ted ▶ 41:54 Ted Challenges Lack of Concern Over Market PricingTed actively challenges Andre's optimistic tone by noting that he has not voiced concern about broad capital market overvaluation and risk.
Biggest teaching moment ▶ 42:10 Mathematical Reality of 60/40 Forward ReturnsAndre educates listeners by breaking down 15 years of S&P multiple expansion against bond yield declines, proving why traditional 60/40 asset allocations face around a 3% real expected return.
Ted holds their own ▶ 26:13 Ted Probes Hit Rates vs Slugging PercentagesTed demonstrates deep allocator expertise by contrasting 55-60% stock picker win rates against binary outcome biotech investing, forcing Andre to clarify how payoff asymmetries operate in the sector.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Ted as informed peer | Guest teaching | Guest disagreement | Ted pushing back | Why |
|---|---|---|---|---|---|---|
| HighVista's Evolution: Moving Beyond Asset Class Buckets | 4 | 3 | 0 | 1 | Ted probes how HighVista shifted from a traditional single-pool endowment model to idiosyncratic opportunities. Andre explains the structural change in macro yields and the necessity of moving away from rigid asset class buckets. | |
| Bottom-Up Networking and Opportunity-Led Portfolio Construction | 4 | 3 | 0 | 1 | Ted asks how HighVista reconciles client expectations of traditional risk exposures with idiosyncratic return streams. Andre explains parsing equity-likeness bottom-up while shifting the unit of analysis from managers to market inefficiencies. | |
| Inefficient Markets and the Biotechnology Investment Landscape | 5 | 4 | 0 | 1 | Ted engages in a deep dive on biotech investing, asking precise questions regarding manager hit rates versus slugging percentages and portfolio concentration. Andre details why large institutional capital cannot participate in small-cap biotech, leaving pricing anomalies for domain experts. | |
| Sourcing Uncorrelated Yield in Niche Private Credit | 3 | 3 | 0 | 0 | Andre outlines idiosyncratic private credit niches such as litigation finance, catastrophe risk, and aviation finance, noting that excess returns stem from labor-intensive structuring rather than macro insight. | |
| Sponsor Message: Ridgeline Front-to-Back Investment Technology | 2 | 2 | 0 | 0 | The segment includes a sponsor message followed by Ted prompting Andre to detail an implementation example in litigation finance, where HighVista backs specialized former litigators. | |
| Assessing Strategy Longevity and Time Arbitrage in Active Management | 4 | 3 | 0 | 0 | Ted asks how Andre differentiates between fleeting market anomalies and enduring products, and questions the future of active management. Andre emphasizes time arbitrage as an enduring edge because public markets rarely look out three to five years. | |
| Private Equity Dynamics, Market Valuations, and Expected Returns | 5 | 4 | 1 | 2 | Ted directly pushes back on Andre's apparent lack of concern regarding high market valuations. Andre responds with a detailed mathematical breakdown showing that multiple expansion drove historical returns and forward 60/40 portfolios face meager real yields. | |
| HighVista's Roadmap and Direct Execution Capabilities | 4 | 3 | 0 | 1 | Ted explores HighVista's internal execution versus external manager allocation. Andre provides a concrete case study from March 2020 dislocations in AAA municipal bonds to illustrate direct opportunistic execution. | |
| Closing Questions: Personal Habits, Mental Models, and Life Lessons | 1 | 1 | 2 | 0 | In the standard closing questions, Andre expresses strong disdain for herd behavior and fake originality in investing, stating that most market participants merely copy others while claiming to do original work. | |
| Bonus Questions: Career Advice, Cultivating Trust, and Life Perspectives | 1 | 1 | 0 | 0 | Ted asks bonus closing questions regarding career advice, building client trust, and life lessons. Andre emphasizes human capital development, calculated risk-taking, and learning from the documentary My Octopus Teacher. |
Statements from this episode (15)
Perold: Alpha is scarce, transient, and quickly competed away
“I've always said, and I still believe that alpha is scarce, and it's transient. It doesn't stick around for very long because it gets competed away. And so you always have to skate to where the puck is going, knowing that it's not going to stay long in any one…”
André Perold: Allocating to asset buckets limits unconstrained investing
“It's very limiting to allocate to buckets and then have to fill the buckets. And it's much better if you can opportunistically look around for the best ideas that may not conform to buckets and then put those together.”
Perold: At least 50% of HighVista is invested in idiosyncratic areas
“I would say today it's at least 50% in the much more idiosyncratic areas and growing.”
Perold: Allocators should focus on the opportunity set, not the manager
“And in fact, change the unit of analysis from the manager to the opportunity set. And so if we discover that a certain market is inefficient, let's say it's European micro caps or something. That's the inefficiency. We should focus on that as the unit of analy…”
Perold: Top-down macro forecasting is hard and almost nobody is good at it
“Those sorts of macro perspectives don't really feature into what we do. They're very hard to get right. We don't know anyone who's any good at it. We certainly are not.”
Perold: China is the rare enormous yet inefficient financial market
“China's the one exception to the rule that an inefficient market is small. It's an enormous market that still seems to be quite inefficient, not just in equities, but in other securities as well.”
Perold: Biotech represents one-seventh of US public companies but only $600B market cap
“At its highest level, you have today some 600 public companies in this country, about out of 4000 total public companies, so it's about a seventh of all public companies in this country are in biotech per se. They small caps, so the total caps about six hundre…”
Perold: Big pharma is bad at R&D, leaving discovery to small biotechs
“The reason they exist is that pharma is not good at R&D. These little firms all do R&D. They do drug discovery on the path to drug commercialization, and what we find, you know, they exist because pharma isn't good at it, and the capital markets have figured o…”
Perold: Credit returns reward hard structuring work rather than genius
“Credit isn't about being a genius investor that has epiphanies all the time. It's really about finding borrowers that need help, finding borrowers that have very high cost of money, and then finding ways to create a loan that's going to give you a very nice re…”
André Perold: Public markets struggle to price three-to-five-year horizons
“The markets are focused on this quarter, next quarter. They don't look out five years. The markets have a great problem looking out five years for some reason. Three to five years is very difficult for people to want to bet on. And they'd like to see near term…”
André Perold: Concentrated active management will always have a place
“So there is absolutely a sense of time arbitrage in the markets. I think you see it in all markets. And as long as that's the case, I think longer dated, concentrated active management will always have a place. I don't see it going, even in the largest cap sto…”
André Perold: S&P 500 gained 9% annually since 2005, 3% from multiples
“You know, the last 15 years that we've been in business, if you look at the return on the S&P, it's nine percent a year since the late 2005. Of the nine, three percent a year has come from multiple expansion, and that three percent a year is entirely consisten…”
André Perold: Standard 60/40 portfolios deliver only 3% expected real return
“Going forward, what's tough is that you think of a 60 40 portfolio 40 of the sixties earning zero. Okay. Zero real, or maybe even negative real. And if your PE is 20, that's an earnings yield of five. Now an earnings yield of five, if bond yields are zero, is …”
Perold: March 2020 dislocation dumped AAA munis from 140 to 80s
“A great example was in March. When the market, it was a massive dislocation. You had mutual funds being redeemed. They were dumping AAA bonds, especially AAA munis were being dumped at crazy prices. AAA bonds that were trading at 140 were selling in the eighti…”
André Perold: Most investors copy others while pretending to do original work
“There are actually very few original thinkers. Everybody copies everybody else, but they all pretend to be doing their own thing. So the peeve is that people claim to be doing original work, but you know, they're just copying other people's stuff. And you see …”